Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD Chronic Kidney Disease Collaboration.
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
Hyperuricemia and its related diseases: mechanisms and advances in therapy.
Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, Pang Y, Zhang C, Zhong Z, Gao J.
Signal Transduct Target Ther. 2024 Aug 28;9(1):212. doi: 10.1038/s41392-024-01916-y.
Glycogen Storage Disease Type I.
Bali DS, El-Gharbawy A, Austin S, Pendyal S, Kishnani PS.
2006 Apr 19 [updated 2021 Oct 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
Mackenzie IS, Ford I, Nuki G, Hallas J, Hawkey CJ, Webster J, Ralston SH, Walters M, Robertson M, De Caterina R, Findlay E, Perez-Ruiz F, McMurray JJV, MacDonald TM; FAST Study Group.
Lancet. 2020 Nov 28;396(10264):1745-1757. doi: 10.1016/S0140-6736(20)32234-0. Epub 2020 Nov 9.
Treatment of gout patients with impairment of renal function: a systematic literature review.
van Echteld IA, van Durme C, Falzon L, Landewé RB, van der Heijde DM, Aletaha D.
J Rheumatol Suppl. 2014 Sep;92:48-54. doi: 10.3899/jrheum.140462.
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.
Saag KG, Whelton A, Becker MA, MacDonald P, Hunt B, Gunawardhana L.
Arthritis Rheumatol. 2016 Aug;68(8):2035-43. doi: 10.1002/art.39654.
Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights.
Mei Y, Dong B, Geng Z, Xu L.
Front Endocrinol (Lausanne). 2022 Jul 14;13:911968. doi: 10.3389/fendo.2022.911968. eCollection 2022.
Managing Gout in the Patient with Renal Impairment.
Pascual E, Sivera F, Andrés M.
Drugs Aging. 2018 Apr;35(4):263-273. doi: 10.1007/s40266-018-0517-7.
Effect of tea intake on genetic predisposition to gout and uric acid: a Mendelian randomization study.
Yu Y, Yang X, Hu G, Tong K, Yin Y, Yu R.
Front Endocrinol (Lausanne). 2024 Feb 2;14:1290731. doi: 10.3389/fendo.2023.1290731. eCollection 2023.
Impact of Hyper- and Hypo-Uricemia on Kidney Function.
Miake J, Hisatome I, Tomita K, Isoyama T, Sugihara S, Kuwabara M, Ogino K, Ninomiya H.
Biomedicines. 2023 Apr 24;11(5):1258. doi: 10.3390/biomedicines11051258.
